B cell-intrinsic epigenetic modulation of antibody responses by dietary fiber-derived short-chain fatty acids

Nat Commun. 2020 Jan 2;11(1):60. doi: 10.1038/s41467-019-13603-6.

Abstract

Short-chain fatty acids (SCFAs) butyrate and propionate are metabolites from dietary fiber's fermentation by gut microbiota that can affect differentiation or functions of T cells, macrophages and dendritic cells. We show here that at low doses these SCFAs directly impact B cell intrinsic functions to moderately enhance class-switch DNA recombination (CSR), while decreasing at higher doses over a broad physiological range, AID and Blimp1 expression, CSR, somatic hypermutation and plasma cell differentiation. In human and mouse B cells, butyrate and propionate decrease B cell Aicda and Prdm1 by upregulating select miRNAs that target Aicda and Prdm1 mRNA-3'UTRs through inhibition of histone deacetylation (HDAC) of those miRNA host genes. By acting as HDAC inhibitors, not as energy substrates or through GPR-engagement signaling in these B cell-intrinsic processes, these SCFAs impair intestinal and systemic T-dependent and T-independent antibody responses. Their epigenetic impact on B cells extends to inhibition of autoantibody production and autoimmunity in mouse lupus models.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies / genetics*
  • Antibodies / immunology
  • Antibodies / metabolism
  • Autoantibodies / genetics
  • Autoantibodies / immunology
  • B-Lymphocytes / drug effects
  • B-Lymphocytes / immunology
  • Butyrates / pharmacology
  • Cytidine Deaminase / antagonists & inhibitors
  • Cytidine Deaminase / genetics
  • Cytidine Deaminase / immunology
  • Cytidine Deaminase / metabolism
  • Dietary Fiber
  • Epigenesis, Genetic / drug effects*
  • Fatty Acids, Volatile / isolation & purification
  • Fatty Acids, Volatile / pharmacokinetics
  • Fatty Acids, Volatile / pharmacology*
  • Female
  • Gastrointestinal Microbiome / drug effects
  • Gastrointestinal Microbiome / genetics
  • Gastrointestinal Microbiome / immunology*
  • Histone Deacetylase Inhibitors / immunology
  • Histone Deacetylase Inhibitors / pharmacology
  • Humans
  • Lupus Erythematosus, Systemic / drug therapy
  • Lupus Erythematosus, Systemic / immunology
  • Mice, Inbred C57BL
  • Mice, Mutant Strains
  • Positive Regulatory Domain I-Binding Factor 1 / antagonists & inhibitors
  • Positive Regulatory Domain I-Binding Factor 1 / genetics
  • Positive Regulatory Domain I-Binding Factor 1 / immunology
  • Positive Regulatory Domain I-Binding Factor 1 / metabolism
  • Propionates / pharmacology
  • Tissue Distribution

Substances

  • Antibodies
  • Autoantibodies
  • Butyrates
  • Dietary Fiber
  • Fatty Acids, Volatile
  • Histone Deacetylase Inhibitors
  • Prdm1 protein, mouse
  • Propionates
  • Positive Regulatory Domain I-Binding Factor 1
  • AICDA (activation-induced cytidine deaminase)
  • Cytidine Deaminase